Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress
Saida Haider, Laraib Liaquat, Saara Ahmad, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227631-e0227631
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Inflammation and aging: signaling pathways and intervention therapies
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 486
Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
Łucja Justyna Walczak-Nowicka, Mariola Herbet
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9290-9290
Open Access | Times Cited: 161
The Chemical Variability, Nutraceutical Value, and Food-Industry and Cosmetic Applications of Citrus Plants: A Critical Review
Anis Ben Hsouna, Carmen Sadaka, Ivana Generalić Mekinić, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 481-481
Open Access | Times Cited: 57
Molecular mechanisms of aluminum neurotoxicity: Update on adverse effects and therapeutic strategies
Anatoly V. Skalny, Michael Aschner, Yue‐Ming Jiang, et al.
Advances in neurotoxicology (2021), pp. 1-34
Open Access | Times Cited: 74
Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease
Samah Labban, Badrah S. Alghamdi, Fahad S. Alshehri, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113100-113100
Open Access | Times Cited: 67
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 48
Neuroprotective effect of naringin against cerebellar changes in Alzheimer’s disease through modulation of autophagy, oxidative stress and tau expression: An experimental study
Hend M Hassan, Mohamed R. Elnagar, E.A. Abdel-Razik, et al.
Frontiers in Neuroanatomy (2022) Vol. 16
Open Access | Times Cited: 41
Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation
Mustafa K Shehata, Assem A Ismail, Maher A. Kamel
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1631-1658
Open Access | Times Cited: 36
The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review
Qian Zhang, Yaping Yan
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2582-2591
Open Access | Times Cited: 30
Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
Heba H. Awad, Mahmoud A. Desouky, Alaa Zidan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2653-2673
Open Access | Times Cited: 27
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 24
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Andleeb Khan, Sadaf Jahan, Zuha Imtiyaz, et al.
Biomedicines (2020) Vol. 8, Iss. 8, pp. 284-284
Open Access | Times Cited: 57
Citrus Polyphenols in Brain Health and Disease: Current Perspectives
Matthew G. Pontifex, Mohammad M. A. H. Malik, Emily Connell, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 54
Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease
Mir Hilal Ahmad, Mahino Fatima, Mansoor Ali, et al.
Neuropharmacology (2021) Vol. 201, pp. 108831-108831
Closed Access | Times Cited: 45
Polyphenols and neurodegenerative diseases: focus on neuronal regeneration
Seyed Zachariah Moradi, Faramarz Jalili, Negin Farhadian, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 13, pp. 3421-3436
Closed Access | Times Cited: 41
Potential therapeutic use of plant flavonoids in AD and PD
Sun Meng-zhen, Li Ju, Lanchun Zhang, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11440-e11440
Open Access | Times Cited: 31
Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile
Sukhwinder Singh, Alok Sharma, Vikramdeep Monga, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8868-8899
Closed Access | Times Cited: 30
Naringenin mitigates nanoparticulate-aluminium induced neuronal degeneration in brain cortex and hippocampus through downregulation of oxidative stress and neuroinflammation
Ravina Rai, Pankaj Lal Kalar, Deepali Jat, et al.
Neurochemistry International (2024) Vol. 178, pp. 105799-105799
Closed Access | Times Cited: 7
A review on the protective effects of naringenin against natural and chemical toxic agents
Karim Naraki, Ramin Rezaee, Gholamreza Karimi
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4075-4091
Closed Access | Times Cited: 38
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
Xiongxiong Liu, Ting Zhao, Zheng Shi, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4947-4947
Open Access | Times Cited: 15
Oral administration of encapsulated catechin in chitosan‐alginate nanoparticles improves cognitive function and neurodegeneration in an aluminum chloride‐induced rat model of Alzheimer's disease
Elnaz Mohammadbaghban, Ali Taravati, Hossein Najafzadehvarzi, et al.
Physiological Reports (2024) Vol. 12, Iss. 13
Open Access | Times Cited: 5
Cognitive Facilitation and Antioxidant Effects of an Essential Oil Mix on Scopolamine-Induced Amnesia in Rats: Molecular Modeling of In Vitro and In Vivo Approaches
Răzvan Ştefan Boiangiu, Ion Brinza, Monica Hăncianu, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1519-1519
Open Access | Times Cited: 36
Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
Jiarui Wu, Xiaodi Kou, Hui Ju, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128316-128316
Closed Access | Times Cited: 32
Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways
Mohamed A. Salem, Barbara Budzyńska, Joanna Kowalczyk, et al.
Toxicology and Applied Pharmacology (2021) Vol. 429, pp. 115697-115697
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top